NCT03105804View on ClinicalTrials.gov

CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Four Different Electronic Cigarettes

NACompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

March 29, 2017

Primary Completion Date

October 27, 2017

Study Completion Date

October 27, 2017

Conditions
Smoking
Interventions
OTHER

FT21039

An electronic cigarette

OTHER

FT21041

An electronic cigarette

OTHER

FT21044

An electronic cigarette

OTHER

FT21042

An electronic cigarette

Trial Locations (2)

27265

High Point Clinical Trials Center, High Point

07753

Inflamax Research, Inc., Neptune City

Sponsors

Collaborators (1)

Davita Clinical Research
All Listed Sponsors
collaborator

Inflamax Research Incorporated

INDUSTRY

collaborator

Davita Clinical Research

INDUSTRY

lead

RAI Services Company

INDUSTRY

NCT03105804 - CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Four Different Electronic Cigarettes | Biotech Hunter | Biotech Hunter